Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

HealthWell Foundation Unveils Fund to Help Patients Living with MASH

May 28, 2024

Among its benefits, the fund will provide up to $8,000 in medication copayment or insurance premium assistance.

Pharma Pulse 5/28/24: Global Insulin Delivery Systems Strategic Research Report 2024, A Fun and Insightful Exploration of Behavioral Science & more

May 28, 2024

The latest news for pharma industry insiders.

Resource Label Group Purchases Beyer Graphics

May 27, 2024

The transaction serves as way to expand customers’ access to products and capabilities.

Pharma Pulse 5/27/24: Cyberattack at Ascension Hospitals Causing Delays in Patient Care, Optimizing Pharmaceutical Innovation Through AI & more

May 27, 2024

The latest news for pharma industry insiders.

Orna Therapeutics Enhances Circular RNA Capabilities, Acquires ReNAgade Therapeutics

May 24, 2024

The deal grows it pipeline, powered by panCAR programs in autoimmune disease and oncology.

MilliporeSigma to Purchase Mirus Bio

May 24, 2024

With the acquisition, Merck’s US and Canada life science business aims to further increase its viral vector manufacturing capabilities.

Pharma Pulse 5/24/24: Pre-Approval Information Exchange to Accelerate Product Success, Walgreens Boots Alliance Sells Shares of Cencora & more

May 24, 2024

The latest news for pharma industry insiders.